Injectafer 750 MG/15 ML vial 15ML
Ended Awarded Last action
- Contract number
- SPE2DR26FN1B6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,473
Award facts
- Contract value 100% obligated
- $10,473.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $10,473.40 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 27, 2026, for the supply of Injectafer 750 mg/15 ml vials. The contract is non-competitive with no set-aside designation and carries an ultimate completion date of January 28, 2026. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the comprehensive global pharmaceutical support vehicle enabling supply of a wide range of medications and medical products to military healthcare programs worldwide.
AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA supply chain. The company's extensive portfolio includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The underlying IDC with DLA Troop Support Medical encompasses specialty medications, prescription drugs, vaccines, syringes, vials, and test kits, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for Injectafer, an iron replacement therapy, represents a routine pharmaceutical supply transaction within the company's established federal contracting relationship.
Quick answers
Who was awarded contract SPE2DR26FN1B6?
SPE2DR26FN1B6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26FN1B6 worth?
The government has obligated $10,473 on SPE2DR26FN1B6.
Is contract SPE2DR26FN1B6 an order under another contract?
Yes. SPE2DR26FN1B6 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FN1B6 competed?
The extent of competition for SPE2DR26FN1B6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award